NCT03460977 2026-03-13A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular LymphomaPfizerPhase 1 Recruiting453 enrolled
NCT07070232 2026-03-12A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant TumorsBioNTech SEPhase 1/2 Recruiting980 enrolled
NCT05150691 2026-01-28A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid TumorsDualityBio Inc.Phase 1/2 Recruiting796 enrolled
NCT06400472 2026-01-14A Study of LY4170156 in Participants With Selected Advanced Solid TumorsEli Lilly and CompanyPhase 1 Recruiting495 enrolled
NCT05914116 2025-11-21A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid TumorsDualityBio Inc.Phase 1/2 Recruiting862 enrolled
NCT02157883 2025-11-19Study to Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of AZD9291, in Patients With EGFR Positive Non-small Cell Lung Cancer. Patients Will be Chosen From Those Who Have Already Been Prescribed an EGFR TKI Medicine (Such as Iressa or Tarceva)AstraZenecaPhase 1 Completed39 enrolled 18 charts
NCT04537715 2025-02-19Effects of Itraconazole and Rifampin on the Blood Tazemetostat LevelsIpsenPhase 1 Completed42 enrolled 39 charts
NCT06348888 2024-06-20A Study to Learn About How Itraconazole and Carbamazepine Affect the Level of BAY2927088 in the Blood When These Drugs Are Taken Together by Healthy ParticipantsBayerPhase 1 Completed30 enrolled